Abstract:Little is known regarding the effects of xylooligosaccharides (XOS) on insulin resistance (IR) in gestational diabetes mellitus (GDM). We aimed to investigate this issue and its mechanism. Sixty female mice were randomly allotted to 4 groups (n=15): control, high fat diet (HFD), GDM, and GDM+XOS. The control mice were fed AIN-93 diet while mice in other groups fed 45% HFD. After pregnancy, mice in GDM and GDM+XOS groups were intraperitoneally injected with 30 mg/kg streptozocin for 3 days from the first day of pregnancy. Mice in GDM+XOS group were then fed HFD containing 2% XOS. Fasting glucose and insulin levels were monitored. The fecal Akkermansia muciniphila (Akk. muciniphila) and Biofidobacterium was measured by qPCR. The Chiu's scores were calculated from hematoxylin-eosin (HE) stained ileal tissues. Phosphorylated Akt in liver and occludin and ZO-1 in intestinal tissues were determined by western blot. XOS reduced (p<0.05) fasting blood glucose and insulin, HOMA-IR, and increased (p<0.05) Akt phosphorylation in liver of GDM mice. Moreover, XOS decreased (p<0.05) TNFα, IL-1β, IL-15 and LPS in serum, increased (p<0.05) fecal Akk. Muciniphila abundance, lowered (p<0.05) Chiu's scores, and enhanced (p<0.05) occludin and ZO-1 expressions. XOS ameliorate IR by increasing Akk. muciniphila and improving intestinal barrier dysfunction in GDM mice.

Xylooligosaccharides (XOS) Ameliorate Insulin Resistance by Increasing Akkermansia Muciniphila and Improving Intestinal Barrier Dysfunction in Gestational Diabetes Mellitus (GDM) Mice